ClinicalTrials.gg
Not yet recruitingNCT05848921Updated May 8, 2023

Evaluation of Brain Health and Surgical Efficacy in Patients With Carotid Artery Stenosis

An observational study in Carotid Artery Stenosis and Image, sponsored by Nanjing University of Traditional Chinese Medicine. Not yet recruiting at 1 site in China. Open to participants aged 50 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-05-08.

Sponsored by Nanjing University of Traditional Chinese Medicine · Observational

From the registry’s dates

  • Primary completion was expected by Dec 2025, 10 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
50 Years to 80 Years
Sex
All
01

Study summary

The purpose of this study is to explore the relationship between the recovery of cerebrovascular morphology and cognitive function before and after surgical treatment in patients with carotid artery stenosis and their preoperative cardiac health status. And combined with preoperative cognitive status, serum markers, and cardiovascular health evaluation indicators, evaluate and predict the possibility of postoperative neurodegenerative diseases and the level of cerebrovascular health in patients.

Read the detailed description

The aim of this study is to evaluate the brain health status and surgical efficacy of patients with carotid artery stenosis. Firstly, investigate whether hemodynamic parameters such as blood flow reserve fraction at the carotid artery stenosis site are correlated with white matter hyperintensities and cerebral vascular morphological changes in elderly patients with normal cognition and mild cognitive impairment; Then, when the blood flow of carotid artery has been improved after surgery, compare the cerebrovascular health of patients before surgery and the way of cerebral vascular reconstruction; Combined with the postoperative neuropsychological cognitive test to explore the postoperative cognitive recovery of patients, and combined with the postoperative imaging data and the biomarker in the blood of patients at various stages, to explore the way of cerebral vascular reconstruction and changes in brain structure and function of different groups of patients behind cognitive changes.

02

Conditions studied

  • Carotid Artery Stenosis
  • Image

Browse trials for

Keywords

  • Carotid Artery Stenosis
  • MRI Imaging
03

In context

Carotid Stenosis

364 studies on the registry are indexed under Carotid Stenosis; 85 are open to participants now.

This study's planned enrollment of 100 is below the median of 176 across 159 observational studies indexed under Carotid Stenosis.

Browse Carotid Stenosis studies →

Lead sponsor

Nanjing University of Traditional Chinese Medicine is the lead sponsor of 17 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

All of the patients of carotid artery stenosis group are in-patients and out-patients in the cardiac surgery department from the research center. The subjects of control group are recruited from community.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged over 50 years old;
  • Conscious and capable of completing neuropsychological scales
  • Clinical detection of carotid artery stenosis requires surgical treatment;
  • Compliant with carotid artery stenting or carotid endarterectomy surgical standards
  • Individuals with normal cognition and mild cognitive impairment

Exclusion criteria

Exclusion Criteria:

  • Degree of vascular blockage in other intracranial segments ≥ 50%
  • Have a history of mental illness, nervous system disease (such as stroke) or brain injury with loss of consciousness for more than five minutes;
  • Neurological and psychiatric disorders unrelated to AD (schizophrenia, depression, etc.), post-traumatic stress disorder, obsessive-compulsive disorder, multiple sclerosis, amyotrophic lateral sclerosis)
  • Have a history of alcohol or drug abuse
  • There are for magnetic resonance imaging examination
  • Those with significant organ dysfunction such as lung, liver, and kidney;
  • Patients with intracranial tumors, infectious diseases, and blood system diseases;
  • Participating in other clinical studies at the same time
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Target follow-up
1 Year
Patient registry
Yes

Groups and cohorts

  • CAS-CN

    Carotid Artery Stenosis with cognitive normality

    Device: magnetic resonance image · Diagnostic Test: Neuropsychological scale

  • CAS-MCI

    Carotid Artery Stenosis with mild cognitive impairment

    Device: magnetic resonance image · Diagnostic Test: Neuropsychological scale

  • HC

    Healthy controls

    Device: magnetic resonance image · Diagnostic Test: Neuropsychological scale

Interventions

  • Devicemagnetic resonance image

    Imaging data were collected in a strong magnetic field

  • Diagnostic testNeuropsychological scale

    Multi dimensional neuropsychological test

06

What researchers measure

Primary outcomes

  1. Change of brain volume before and after treatment

    The change of brain volume (mm3) are evaluated by structural 3DT1 weighted MRI. Freesurfer software is used to get the measured value of the volume.

    Time frame: before operation; 3-10 Days after operation; 1 month; 6-12months]

  2. Change of cerebrovascular morphology before and after treatment

    The change of Cerebral vessel density, caliber and tortuosity, brain white matter hyperintensity lesion count

    Time frame: before operation; 3-10 Days after operation; 1 month; 6-12months

  3. Change of brain function connectivity before and after operation

    The change of brain functional connectivity intensity are evaluated by rest stage functional MRI. DPABI software based on MATLAB is used to get the measured the matrix value of functional connectivity.

    Time frame: before operation; 3-10 Days after operation; 1 month; 6-12months

Secondary outcomes

  1. Change of serum marker concentration before and after operation

    The change of serum marker concentration is evaluated by inflammatory cytokine.

    Time frame: before operation; 3-10 Days after operation; 1 month; 6-12months

  2. Change of plasma marker concentration before and after operation

    The change of plasma marker concentration is evaluated by neurofilament light chain(NFL) protein extracted from plasma.

    Time frame: before operation; 3-10 Days after operation; 1 month; 6-12months

  3. Brain evaluate basic cognition before operation

    Basic cognition is evaluated by Mini-mental State Examination (MMSE) and Clinical Dementia Rating (CDR) . For MMSE , The minimum value is 0 , and the maximum value is 30. The higher scores mean a better outcome. For CDR , the results are represented by scores of 0,0.5,1,2,3, and the degree of cognitive impairment is classified as normal, suspicious, mild, moderate, and severe

    Time frame: before operation

  4. Change of executive functions before and after operation evaluated by Trail-Making Test Part A

    The change of executive functions are first evaluated by Trail-Making Test Part A test. The minimum value is 0 , and the maximum value is 30. This test has no clear maximum and minimum values. If the test completion time exceeds 79 seconds, it means the outcome is abnormal. The higher scores mean a worse outcome.

    Time frame: before operation; 3-10 Days after operation; 1 month; 6-12months

  5. Change of executive functions before and after operation evaluated by Digit Symbol Coding score

    The change of executive functions are second evaluated by Digit Symbol Coding score. The minimum value is 0 , and the maximum value is not clear. The normal range of results is 56.53 ± 20.17. The higher scores mean a better outcome.

    Time frame: before operation; 3-10 Days after operation; 1 month; 6-12months

  6. Change of working memory before and after operation evaluated by Forward Digit Span

    The change of working memory is first evaluated by Forward Digit Span. The minimum value is 0 , and the maximum value is not clear. The normal range of results is 7.75±1.47. The higher scores mean a better outcome.

    Time frame: before operation; 3-10 Days after operation; 1 month; 6-12months

  7. Change of working memory before and after operation evaluated by Backward Digit Span

    The change of working memory is second evaluated by Backward Digit Span. The minimum value is 0 , and the maximum value is not clear. The normal range of results is 5.36±1.91. The higher scores mean a better outcome.

    Time frame: before operation; 3-10 Days after operation; 1 month; 6-12months

  8. Change of language function before and after operation evaluated by Language Fluency test

    The change of language function is evaluated by Language Fluency test. The minimum value is 0 , and the maximum value is not clear. The normal range of results is 19.43±4.81. The higher scores mean a better outcome.

    Time frame: before operation; 3-10 Days after operation; 1 month; 6-12months

  9. Change of executive functions before and after operation evaluated by Clock Drawing Test

    The change of executive functions is evaluated by Backward Digit Span. The minimum value is 0 , the maximum value is 4.

    Time frame: before operation; 3-10 Days after operation; 1 month; 6-12months

  10. Change of executive functions before and after operation evaluated by Trail-Making Test Part B

    The change of executive functions are first evaluated by Trail-Making Test Part B test. The minimum value is 0 , and the maximum value is 30. This test has no clear maximum and minimum values. If the test completion time exceeds 79 seconds, it means the outcome is abnormal. The higher scores mean a worse outcome.It is a supplement to Trail-Making Test Part A, which is optional for patients who are not familiar with the English alphabetical order

    Time frame: before operation; 3-10 Days after operation; 1 month; 6-12months

07

Study locations

1 site
  • The 2rd School of Medicine,WMU/The 2rd Affiliated Hospital and Yuying Children's Hospiyal of WMU
    Wenzhou, Zhejiang, China
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 8, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05848921
Lead sponsor
Nanjing University of Traditional Chinese Medicine
Collaborators
Xi'an Jiaotong University, The 2rd School of Medicine,WMU/The 2rd Affiliated Hospital and Yuying Children's Hospiyal of WMU
Responsible party
Qianyan Liu (Principal Investgator, Nanjing University of Traditional Chinese Medicine) — Principal investigator
First posted
May 8, 2023
Start date
May 1, 2023 (estimated)
Primary completion
Dec 31, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
May 8, 2023

Study contacts

Bo Yin, phD
Contact
76yinbo@163.com
0086-13857773745
Lijun Bai, phD
Contact
bailijun@xjtu.edu.cn
0086-15129034948
Bo Yin, phD
principal investigator · The 2rd School of Medicine,WMU/The 2rd Affiliated Hospital and Yuying Children's Hospiyal of WMU

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion